GET IN TOUCH

Robert R Ruffolo, PhD

Director

Robert Ruffolo is a distinguished scientist, globally recognized for his executive leadership in the pharmaceutical industry. He served as the President of R&D and Senior Vice President of Wyeth Pharmaceuticals (now, Pfizer) from 2002 to 2008. Prior to Wyeth, Dr Ruffolo served as Senior Vice President, R&D, at SmithKline Beecham Pharmaceuticals (now, GlaxoSmithKline) for 17 years. He has played a significant role in the discovery and development of a number of successful products, including Carvedilol, Ropinirole, Dobutamine and Eprosartan. 

Dr Ruffolo has won several prestigious awards, including the Discoverer’s Award in 2008 for his pioneering work on the discovery of Carvedilol for the treatment of congestive heart failure. He has published over 500 full-length publications, edited 15 books, and was Editor-in-Chief of four international pharmacology journals. Dr Ruffolo was appointed to Aragen’s (formerly, GVK BIO) Board of Directors in April 2019.

Professional Experience

  • President, R&D and Senior Vice President, Wyeth Pharmaceuticals (now, Pfizer) (2002–2008)
  • Senior Vice President, R&D, SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline)
  • Chairman, Cardiovascular Research Committee, Eli Lilly and Company

Leadership

  • Director, Sigilon Therapeutics
  • Director, Elucida Oncology
  • Director, Sapience Therapeutics
  • Director, Aridis Pharmaceuticals
  • Director, Elicio Oncology
  • President, Ruffolo Consulting LLC (since 2008)

Education

  • PhD in Pharmacology, The Ohio State University, USA
  • BSc (Summa Cum Laude, and with Distinction) in Pharmacy, The Ohio State University, USA
  • Honorary Doctorate in Science (DSc), West Virginia University, USA
  • Honorary Doctorate in Engineering (DEng), University of Catania, Italy

Board of Directors

Davinder Singh Brar

Chairman

D S Brar is a life sciences industry veteran, with a career spanning over four decades. Prior to joining Aragen (formerly known as GVK BIO) as Promoter-Chairman,...

G V Sanjay Reddy

Vice Chairman

Sanjay Reddy is the Founder-Vice Chairman of Aragen (formerly known as GVK BIO), and a successful entrepreneur with interests in energy, airports, transportation,...

Sahajbir Singh Brar

Director

Sej Brar is a Partner with L.E.K. Consulting’s global healthcare practice. He has over fifteen years of experience in advising leading global biopharma...

G Indira K Reddy

Director

Indira Reddy entered into business in 1986, and has since built a long and successful career as Managing Director and Director of several companies. In...

G V Keshav Reddy

Director

As a Promoter-Director at Aragen, Keshav Reddy leads board-mandated strategic projects in finance, M&A, branding, structuring and vision planning for...

Robert R Ruffolo, PhD

Director

Robert Ruffolo is a distinguished scientist, globally recognized for his executive leadership in the pharmaceutical industry. He served as the President...

Gerhard Mayr

Director

After 32 years of service, Gerhard Mayr retired as the Executive Vice President, Pharmaceutical Operations at Eli Lilly and Company, in March 2004. At...

Rajat Sood

Director

Rajat Sood is a Managing Director in the Asset Management Division at Goldman Sachs, focused on corporate and growth equity investing in India. Mr. Sood...

Adam Dawson

Director

Adam Dawson is a Managing Director in the Asset Management Division of Goldman Sachs, where he is responsible for equity investing in the healthcare and...

Ajay Srivastava

Director

Ajay Srivastava, has worked with Citibank in the area of Transactional Services and Corporate and Investment Banking for many years. Thereafter, he founded...

Manni Kantipudi

Director & CEO

Manni Kantipudi joined Aragen (formerly known as GVK BIO) in 2007 as President. He is presently CEO and member of the Board of Directors, responsible for...